Skip to main content
FDA Approves First-in-Class Drug for Lower-Risk Myelodysplastic Syndromes
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA Approves First-in-Class Drug for Lower-Risk Myelodysplastic Syndromes
User login
Username
Password
Reset your password
Concept
Lead
score
Myelodysplastic Syndrome
1
1
Transfusion
0
0.82
COVID-19
0
0.52
Blood
0
0.48
Toxicology
0
0.48
Headache
0
0.3
Aminotransferase
0
0.14
Anemia
0
0.14
Hemoglobin
0
0.14
Cancer
0
0.07
Fatigue
0
0.07
Florida
0
0.07
Food and Drug Administration (FDA)
0
0.07
Intravenous
0
0.07
Neutrophils
0
0.07
Orphan Drugs
0
0.07
Platelet Count
0
0.07
Refractory
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Pharmacist
0
1
Public Health & Prevention
0
0.82
Neurology & Neurosurgery
0
0.73
Pulmonary Medicine
0
0.73
Infectious Diseases
0
0.52
Emergency Medicine
0
0.3
Edit Tags